​

Quantum-Si Stock (NASDAQ:QSI)

RevenueOwnershipFinancialsChartTranscripts
Quantum-Si by TradingView

Previous Close

$1.21

52W Range

$0.61 - $5.77

50D Avg

$1.33

200D Avg

$1.34

Market Cap

$216.11M

Avg Vol (3M)

$7.03M

Beta

2.75

Div Yield

-

QSI Company Profile

Quantum-Si incorporated, a life sciences company, develops a single molecule detection platform for sample preparation and sequencing. It offers a proprietary single molecule detection platform for use in semiconductor industry to field proteomics to enable next generation protein sequencing. The company was incorporated in 2013 is based in Guilford, Connecticut.

Show More

Industry

Biotechnology

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

149

IPO Date

Nov 13, 2020

Website

QSI Performance

Revenue Breakdown

Revenue Breakdown by Product/Service

Product/ServiceDec 24Dec 23
Product$2.92M$1.03M
Service$133.00K$51.00K

Fiscal year ends in Dec 24 | Currency in USD

QSI Financial Summary

Dec 24Dec 23Dec 22
Revenue$3.06M$1.08M-
Operating Income$-108.58M$-111.17M$-123.84M
Net Income$-101.01M$-95.96M$-141.04M
EBITDA$-108.58M$-91.80M$-129.86M
Basic EPS$-0.71$-0.68$-1.01
Diluted EPS$-0.71$-0.68$-1.01

Fiscal year ends in Dec 24 | Currency in USD

Latest Earnings Call Transcripts

Q4 24Mar 03, 25 | 4:30 PM
Q3 24Nov 12, 24 | 8:00 AM
Q2 24Aug 07, 24 | 4:30 PM

Peer Comparison

TickerCompany
HCWBHCW Biologics Inc.
HRTXHeron Therapeutics, Inc.
MNOVMediciNova, Inc.
EDITEditas Medicine, Inc.
BDTXBlack Diamond Therapeutics, Inc.
ALECAlector, Inc.
BEAMBeam Therapeutics Inc.
VERVVerve Therapeutics, Inc.
SEERSeer, Inc.
NRIXNurix Therapeutics, Inc.
CRSPCRISPR Therapeutics AG
RNAAvidity Biosciences, Inc.
NTLAIntellia Therapeutics, Inc.
PASGPassage Bio, Inc.
PRMEPrime Medicine, Inc.
HOOKHOOKIPA Pharma Inc.
CRBUCaribou Biosciences, Inc.
ABOSAcumen Pharmaceuticals, Inc.